HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Andrew McConaghie

Senior Writer

Andrew is a London-based journalist who has been writing about pharma, biotech and healthcare for over 20 years.

He writes on a range of topics, including biopharma R&D and commercial issues, digital healthcare and issues affecting patients and global healthcare systems, especially the UK’s NHS.

Latest From Andrew McConaghie

More Encouraging Real World Data From UK – But Can It Turn Around European Sentiment On AZ COVID-19 Vaccine?

Another real-world study from the UK’s rapid vaccine rollout provides evidence that Pfizer’s vaccine saves lives, with the AZ shot matching it on cutting hospitalizations.

Commercial Coronavirus COVID-19

Novavax Sets Out Vaccine Strategy For New COVID-19 Variants

The US company is poised to file with regulators in Q2, but is also looking for longer-term competitive advantage in its variant strategy.

Companies Coronavirus COVID-19

EU Resets Industry Relations In Pursuit Of Summer COVID-19 Vaccination Goal

The EU has just become the world’s biggest buyer of COVID-19 vaccines – and wants to make that purchasing power count in 2021 and beyond.

Europe Coronavirus COVID-19

Roche Gets Long-Awaited Green Light For COVID-19 Cocktail In EU

Key committee was asked to fast-track a decision on the antibody cocktail, but lack of mortality data could mean patchy uptake seen in US repeated in the EU.

BioPharmaceutical Commercial

COVID-19 Vaccine Gives Moderna $18bn Launchpad Into HIV Vaccine, Cancer Therapies

A rush of additional orders from countries around the world has boosted the company’s prospects, and fueled its ambitions beyond COVID-19.

Companies Commercial

CEOs Face Grilling On Vaccine Supply In EU

AstraZeneca's CEO and other leaders from COVID-19 vaccine companies will face some tough questions in Brussels, but the European Commission wants to put differences behind it and solve the vaccine supply problem as soon as possible.

Companies Commercial
See All
UsernamePublicRestriction

Register